Overall, we demonstrated that the hypomethylating agent DAC had an impact on both GDC and GIC cell surface phenotype, favouring cell death mediated by a recombinant FASL compound or by glioma-specific CTLs. This evidence concerns the gene FASLG and central nervous system cancer.